Transcriptional gene silencing of HPV16 E6/E7 induces growth inhibition via apoptosis in vitro and in vivo
- 29 February 2012
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 124 (2), 296-302
- https://doi.org/10.1016/j.ygyno.2011.10.028
Abstract
No abstract availableKeywords
Funding Information
- Special Research Fund for Health Nonprofit Industry (200802109)
- National Nature Science Funds (30973173)
- Zhejiang Province Nature Foundation (Y2100322)
This publication has 42 references indexed in Scilit:
- Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancersCancer Gene Therapy, 2010
- Distribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province, ChinaInternational Journal of Gynecologic Cancer, 2008
- New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancerCancer Gene Therapy, 2007
- RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53Apoptosis, 2007
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Human papillomaviruses: targeting differentiating epithelial cells for malignant transformationOncogene, 2003
- Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysisBritish Journal of Cancer, 2003
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysateThe EMBO Journal, 2001
- Human papillomavirus is a necessary cause of invasive cervical cancer worldwideThe Journal of Pathology, 1999